IHL Shareholders meeting Melbourne 24 August 23
Masses of information and moving parts, shared last night. So apologies if not all correct.
Was keen to get a “feel” for the team, and their ability to successfully manage cross border, time zones, fast pace, and multiple projects.
Joel very pumped, articulate, and driven, but feel there is good balance from Chairman (Troy Valentine) and no doubt other Board Members. Additional resources being added. Head of Corporate Development (USA based), will concentrate on Co-funding, Outsourcing, Joint Development, Acquisition
Three way confirmation of the value of Bob Clark.
- Due the extensive due diligence he conducted before agreeing to join (am sure he would have had many other global offers)
- Has not been on any other Boards (outside his employer)
- Has a significant track record in successful FDA/IND submissions. 35 years in the game and a 15/15 hit rate. He is incentivised to get results
- Good to see focus on key assets, with structured project management teams allocated
- AUD research and development remains, enabling R &D Tax breaks on well resourced and managedprojects (and can’t help thinking this would be an attractive piece for partner/acquirer)
- Clarion Clinics has had excellent patient enquiry response, PR campaign about to ramp up in this area, and assumptions about profit margin looking good.
- Top 40 shareholders hold 47% of company.
- For Redomicile on Nasdaq: IXL need to get shareholder vote across the line.
- Alternative (delisting (ASX) without shareholder support) not palatable, but IHL is not staying on ASX - multiple reasons for others to expand on.
- Important for holders to ensure Automic has current email, contact telephone and postal address for information to be sent.
- Work in progress to make transition to NASDAQ as seamless as possible. A full recommendation about USA share registry/broker, tax information from Pitcher Partners and other requirements, will be released shortly in a package.
- Lots building behind the scenes for release post Nasdaq listing
- Among other things first time attending JP MORGAN Annual Healthcare Conference will take place on January 8-11, 2024 in San Francisco, CA. (Appears to be a significant showcase opportunity)
Thank you Tossy Dog for organising catch up. And a big thank you to Oldpa for “proofing” my comments..
Be greedy when others are fearful :Buffett (and Malkazoid)and maybe VON!
